Selection of the appropriate method for the assessment of insulin resistance

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Borai, Anwar ^a,b   Livingstone, Callum ^c,d   Kaddam, Ibrahim ^a   Ferns, Gordon ^e  

^a KING KHALID NATIONAL GUARD HOSPITAL   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^e KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINISM; INSULIN RESISTANCE; METABOLIC SYNDROME X; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; METABOLIC SYNDROME X; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 81555230504     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-158     Document Type: Review

References (74)

1. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C, N Engl J Med 1988 318 19 1217 1225
2. The biochemical assessment of insulin resistance. Borai A, Livingstone C, Ferns G, Ann Clin Biochem 2007 44 324 342 (Pubitemid 351724669)
3. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S, J Clin Endocrinol Metab 1993 76 2 275 278 (Pubitemid 23073040)
4. Serum insulin-like growth factor binding protein-1: an improvement over other simple indices of insulin sensitivity in the assessment of subjects with normal glucose tolerance. Borai A, Livingstone C, Zarif H, Ferns G, Ann Clin Biochem 2009 46 Pt 2 109 113
5. IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Maddux BA, Chan A, Mandarino LJ, Goldfine ID, Diabetes Care 2006 29 7 1535 1537 (Pubitemid 44127577)
6. The assessment of insulin resistance in man. Wallace TM, Matthews DR, Diabet Med 2002 19 7 527 534 (Pubitemid 35300672)
7. Evaluation of insulin sensitivity in clinical practice and in research settings. Monzillo LU, Hamdy O, Nutr Rev 2003 61 12 397 412 (Pubitemid 38140057)
8. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Groop LC, Widen E, Ferrannini E, Diabetologia 1993 36 12 1326 1331 (Pubitemid 23353035)
9. How can we measure insulin sensitivity/resistance? Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard JP, Diabetes Metab 2011 37 3 179 188
10. Glucose clamp technique: a method for quantifying insulin secretion and resistance. DeFronzo RA, Tobin JD, Andres R, Am J Physiol 1979 237 3 214 223
11. Quantitative estimation of insulin sensitivity. Bergman RN, Ider YZ, Bowden CR, Cobelli C, Am J Physiol 1979 236 6 667 677
12. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD, Sands RE, Pei D, Savage PJ, Bergman RN, Diabetes 1994 43 9 1114 1121 (Pubitemid 24265473)
13. Minimal models of glucose disappearance: lessons from the labelled IVGTT. Caumo A, Giacca A, Morgese M, Pozza G, Micossi P, Cobelli C, Diabet Med 1991 8 9 822 832
14. How to measure hepatic insulin resistance? Choukem SP, Gautier JF, Diabetes Metab 2008 34 6 Pt 2 664 673
15. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. Shen SW, Reaven GM, Farquhar JW, J Clin Invest 1970 49 12 2151 2160
16. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M, J Clin Endocrinol Metab 1989 68 2 374 378 (Pubitemid 19052880)
17. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC, Diabetologia 1985 28 7 401 411 (Pubitemid 15018831)
18. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R, Circulation 1996 93 10 1809 1817
19. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, Shiffman ML, Clore J, Mills AS, Clin Gastroenterol Hepatol 2004 2 12 1107 1115 (Pubitemid 40037642)
20. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Bergman RN, Diabetes 1989 38 12 1512 1527 (Pubitemid 20006675)
21. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Matsuda M, DeFronzo RA, Diabetes Care 1999 22 9 1462 1470 (Pubitemid 29418240)
22. Measuring and estimating insulin resistance in clinical and research settings. Matsuda M, Nutr Metab Cardiovasc Dis 2010 20 2 79 86
23. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R, Diabetes Care 2003 26 12 3320 3325 (Pubitemid 37466894)
24. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic finnish offspring of type 2 diabetic individuals. Lorenzo C, Haffner SM, Stancakova A, Laakso M, J Clin Endocrinol Metab 2011 95 11 5082 5090
25. Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome. Carnevale Schianca GP, Sainaghi PP, Castello L, Rapetti R, Limoncini AM, Bartoli E, Diabetes Metab Res Rev 2006 22 2 111 117
26. Surrogate markers of insulin resistance in assessing individuals with new categories "prehypertension" and "prediabetes". Kanauchi M, Kanauchi K, Inoue T, Kimura K, Saito Y, Clin Chem Lab Med 2007 45 1 35 39 (Pubitemid 46155557)
27. Insulin: in search of a syndrome. Ferrannini E, Balkau B, Diabet Med 2002 19 9 724 729 (Pubitemid 35013849)
28. Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Mason C, Foster-Schubert KE, Imayama I, Kong A, Xiao L, Bain C, Campbell KL, Wang CY, Duggan CR, Ulrich CM, et al. American journal of preventive medicine 2011 41 4 366 375
29. Insulin sensitivity (Si) assessment in lean and overweight subjects using two different protocols and updated software. Borai A, Livingstone C, Shafi S, Zarif H, Ferns G, Scand J Clin Lab Invest 2010 70 2 98 103
30. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA, Diabetes Care 2007 30 1 89 94 (Pubitemid 46052504)
31. Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review. Balion CM, Raina PS, Gerstein HC, Santaguida PL, Morrison KM, Booker L, Hunt DL, Clin Chem Lab Med 2007 45 9 1180 1185 (Pubitemid 47396262)
32. Assessment of insulin sensitivity from measurements in fasting state and during an oral glucose tolerance test in obese children. Atabek ME, Pirgon O, J Pediatr Endocrinol Metab 2007 20 2 187 195 (Pubitemid 46865069)
33. Revised concept for the estimation of insulin sensitivity from a single sample. Raynaud E, Perez-Martin A, Brun JF, Benhaddad AA, Mercier J, Diabetes Care 1999 22 6 1003 1004 (Pubitemid 29241063)
34. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Hermans MP, Levy JC, Morris RJ, Turner RC, Diabetologia 1999 42 6 678 687 (Pubitemid 29265585)
35. A lipid-parameter-based index for estimating insulin sensitivity and identifying insulin resistance in a healthy population. Disse E, Bastard JP, Bonnet F, Maitrepierre C, Peyrat J, Louche-Pelissier C, Laville M, Diabetes Metab 2008 34 5 457 463
36. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 7 412 419 (Pubitemid 15018832)
37. Use and abuse of HOMA modeling. Wallace TM, Levy JC, Matthews DR, Diabetes Care 2004 27 6 1487 1495 (Pubitemid 38680001)
38. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L, J Clin Endocrinol Metab 2001 86 10 4776 4781 (Pubitemid 33020519)
39. Incorporation of the fasting free fatty acid concentration into quantitative insulin sensitivity check index improves its association with insulin sensitivity in adults, but not in children. Ijzerman RG, Stehouwer CD, Serne EH, Voordouw JJ, Smulders YM, Delemarre-van de Waal HA, van Weissenbruch MM, Eur J Endocrinol 2009 160 1 59 64
40. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function]. Li X, Zhou ZG, Qi HY, Chen XY, Huang G, Zhong Nan Da Xue Xue Bao Yi Xue Ban 2004 29 4 419 423
41. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. Quon MJ, J Clin Endocrinol Metab 2001 86 10 4615 4617 (Pubitemid 33020494)
42. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Albareda M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R, Diabetologia 2000 43 12 1507 1511 (Pubitemid 32734856)
43. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M, Diabetes Care 2000 23 1 57 63 (Pubitemid 30022895)
44. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T, Shoji T, Okuno Y, Morii H, Diabetes Care 1999 22 5 818 822 (Pubitemid 29220786)
45. Assessment of insulin sensitivity from a single sample. Fukushima M, Taniguchi A, Sakai M, Doi K, Nagata I, Nagasaka S, Tokuyama K, Nakai Y, Diabetes Care 2000 23 9 1434 1435
46. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ, J Clin Endocrinol Metab 2000 85 7 2402 2410 (Pubitemid 32269192)
47. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, Tahara H, Koyama H, Shoji T, Inaba M, et al. J Clin Endocrinol Metab 2004 89 3 1481 1484 (Pubitemid 38368454)
48. Reproducibility of HOMA and QUICKI among individuals with variable glucose tolerance. Borai A, Livingstone C, Farzal A, Kholeif M, Wang T, Ferns G, Diabetes Metab 2010 36 3 247 249
49. Biological variation of homeostasis model assessment-derived insulin resistance in type 2 diabetes. Jayagopal V, Kilpatrick ES, Jennings PE, Hepburn DA, Atkin SL, Diabetes Care 2002 25 11 2022 2025 (Pubitemid 41071062)
50. [Metformin hydrochloride ameliorates adiponectin levels and insulin sensitivity in adolescents with metabolic syndrome]. Liang L, Fu JF, Zou CC, Hong F, Wang CL, Wang XM, Zhonghua Er Ke Za Zhi 2006 44 2 118 121
51. A comparative study of insulin resistance for Saudi and Caucasian subjects across a range of glycaemic categories. Borai A, Callum L, Hawazen Z, Shweta M, Mona K, Mohammed A, Hanin A, Gordon F, Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2009 3 204 210
52. Comparison of 11 human insulin assays: implications for clinical investigation and research. Manley SE, Stratton IM, Clark PM, Luzio SD, Clin Chem 2007 53 5 922 932 (Pubitemid 46744250)
53. Preanalytical, analytical, and computational factors affect homeostasis model assessment estimates. Manley SE, Luzio SD, Stratton IM, Wallace TM, Clark PM, Diabetes Care 2008 31 9 1877 1883
54. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: the implication of metabolic syndrome to detect insulin resistance. Esteghamati A, Ashraf H, Esteghamati AR, Meysamie A, Khalilzadeh O, Nakhjavani M, Abbasi M, Diabetes Res Clin Pract 2009 84 3 279 287
55. [Sensitivity and specificity of metabolic syndrome criteria for insulin resistance diagnosis in Spanish population]. Merino-Ibarra E, Cenarro A, Martin P, Garcia-Otin AL, Goicoechea J, Guallar A, Calvo L, Civeira F, Medicina clinica 2007 128 5 168 171 (Pubitemid 46382323)
56. Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance. Ferrara CM, Goldberg AP, Diabetes Care 2001 24 2 245 249 (Pubitemid 32119119)
57. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. Katsuki A, Sumida Y, Urakawa H, Gabazza EC, Murashima S, Morioka K, Kitagawa N, Tanaka T, Araki-Sasaki R, Hori Y, et al. J Clin Endocrinol Metab 2002 87 11 5332 5335 (Pubitemid 35316381)
58. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. Legro RS, Finegood D, Dunaif A, J Clin Endocrinol Metab 1998 83 8 2694 2698 (Pubitemid 28493762)
59. Indices of insulin action calculated from fasting glucose and insulin reflect hepatic, not peripheral, insulin sensitivity in African-American and Caucasian adolescents. Hoffman RP, Pediatric diabetes 2008 9 3 Pt 2 57 61 (Pubitemid 351784996)
60. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. Kalme T, Seppala M, Qiao Q, Koistinen R, Nissinen A, Harrela M, Loukovaara M, Leinonen P, Tuomilehto J, J Clin Endocrinol Metab 2005 90 3 1550 1556 (Pubitemid 40464017)
61. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome. Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM, Exp Clin Endocrinol Diabetes 2006 114 7 371 376 (Pubitemid 44265569)
62. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB, J Clin Endocrinol Metab 2006 91 3 843 850 (Pubitemid 43357748)
63. [Relationship between the triglyceride/high-density lipoprotein- cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome]. Roa Barrios M, Arata-Bellabarba G, Valeri L, Velazquez-Maldonado E, Endocrinol Nutr 2009 56 2 59 65
64. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, et al. Metabolism 2008 57 2 268 273
65. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O'Rahilly S, Balkau B, Flyvbjerg A, Walker M, Hojlund K, Nolan JJ, et al. Diabetologia 2009 52 11 2345 2349
66. Metabolic syndrome racial differences in adolescents. Hoffman RP, Curr Diabetes Rev 2009 5 4 259 265
67. The biological variation of sex hormone-binding globulin in type 2 diabetes: implications for sex hormone-binding globulin as a surrogate marker of insulin resistance. Jayagopal V, Kilpatrick ES, Jennings PE, Holding S, Hepburn DA, Atkin SL, Diabetes Care 2004 27 1 278 280 (Pubitemid 38196751)
68. Biological variation in fasting serum insulin-like growth factor binding protein-1 (IGFBP-1) among individuals with a varying glucose tolerance. Borai A, Livingstone C, Mehta S, Zarif H, Abdelaal F, Ferns G, Clin Biochem 2009 42 12 1270 1274
69. Within-subject biological variation in disease: collated data and clinical consequences. Ricos C, Iglesias N, Garcia-Lario JV, Simon M, Cava F, Hernandez A, Perich C, Minchinela J, Alvarez V, Domenech MV, et al. Ann Clin Biochem 2007 44 Pt 4 343 352 (Pubitemid 351724670)
70. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC, Am J Epidemiol 2000 151 2 190 198 (Pubitemid 30463650)
71. Relationship between Plasma Adiponectin Levels and the Metabolic Syndrome among Korean People. Kim SM, Cho KH, Park HS, Endocr J 2006 53 2 247 254
72. Validation of a simple index (SIisOGTT) of insulin sensitivity in a population of sedentary men. Pigeon E, Riou ME, St-Onge J, Couillard E, Tremblay A, Marette A, Weisnagel SJ, Joanisse DR, Diabetes Metab 2009 35 5 398 403
73. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes. Sarafidis PA, Lasaridis AN, Nilsson PM, Pikilidou MI, Stafilas PC, Kanaki A, Kazakos K, Yovos J, Bakris GL, J Hum Hypertens 2007 21 9 709 716 (Pubitemid 47335301)
74. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Belfiore F, Iannello S, Volpicelli G, Mol Genet Metab 1998 63 2 134 141 (Pubitemid 28453331)